CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 187 filers reported holding CARA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $539,332 | -39.6% | 321,031 | +1.8% | 0.00% | – |
| Q2 2023 | $892,670 | -52.2% | 315,431 | -17.0% | 0.00% | – |
| Q1 2023 | $1,865,900 | -64.8% | 380,020 | -23.0% | 0.00% | -100.0% |
| Q4 2022 | $5,303,574 | +31.8% | 493,815 | +14.9% | 0.00% | 0.0% |
| Q3 2022 | $4,024,000 | +52.7% | 429,964 | +49.0% | 0.00% | – |
| Q2 2022 | $2,635,000 | -10.5% | 288,644 | +19.1% | 0.00% | – |
| Q1 2022 | $2,943,000 | +5.6% | 242,265 | +5.9% | 0.00% | – |
| Q4 2021 | $2,786,000 | -44.3% | 228,703 | -29.4% | 0.00% | -100.0% |
| Q3 2021 | $5,002,000 | -19.5% | 323,760 | -25.7% | 0.00% | 0.0% |
| Q2 2021 | $6,215,000 | +22.8% | 435,512 | +86.8% | 0.00% | 0.0% |
| Q1 2021 | $5,062,000 | +154.8% | 233,168 | +77.6% | 0.00% | – |
| Q4 2020 | $1,987,000 | +228.4% | 131,308 | +176.4% | 0.00% | – |
| Q3 2020 | $605,000 | -31.3% | 47,512 | -7.7% | 0.00% | – |
| Q2 2020 | $881,000 | -13.5% | 51,479 | -33.2% | 0.00% | – |
| Q1 2020 | $1,018,000 | -11.9% | 77,079 | +7.4% | 0.00% | – |
| Q4 2019 | $1,156,000 | +73.3% | 71,743 | +96.6% | 0.00% | – |
| Q3 2019 | $667,000 | +47.2% | 36,501 | +73.2% | 0.00% | – |
| Q2 2019 | $453,000 | -27.1% | 21,074 | -33.4% | 0.00% | – |
| Q1 2019 | $621,000 | -74.9% | 31,635 | -83.4% | 0.00% | -100.0% |
| Q4 2018 | $2,475,000 | +27.1% | 190,440 | +134.1% | 0.00% | – |
| Q3 2018 | $1,948,000 | +33.0% | 81,338 | +6.3% | 0.00% | – |
| Q2 2018 | $1,465,000 | +56.0% | 76,498 | +0.8% | 0.00% | – |
| Q1 2018 | $939,000 | -65.4% | 75,915 | -65.7% | 0.00% | -100.0% |
| Q4 2017 | $2,711,000 | +10.0% | 221,495 | +23.0% | 0.00% | 0.0% |
| Q3 2017 | $2,465,000 | -69.6% | 180,079 | -65.9% | 0.00% | -50.0% |
| Q2 2017 | $8,118,000 | -33.6% | 527,502 | -20.7% | 0.00% | 0.0% |
| Q1 2017 | $12,234,000 | +811.6% | 665,212 | +360.3% | 0.00% | – |
| Q4 2016 | $1,342,000 | -6.9% | 144,524 | -16.4% | 0.00% | – |
| Q3 2016 | $1,442,000 | +600.0% | 172,819 | +304.6% | 0.00% | – |
| Q2 2016 | $206,000 | +110.2% | 42,717 | +172.0% | 0.00% | – |
| Q1 2016 | $98,000 | -73.7% | 15,706 | -28.9% | 0.00% | – |
| Q4 2015 | $373,000 | -29.8% | 22,079 | -40.6% | 0.00% | – |
| Q3 2015 | $531,000 | +201.7% | 37,145 | +157.7% | 0.00% | – |
| Q2 2015 | $176,000 | +16.6% | 14,416 | -3.9% | 0.00% | – |
| Q1 2015 | $151,000 | +7450.0% | 14,994 | +6874.0% | 0.00% | – |
| Q4 2014 | $2,000 | -95.3% | 215 | -95.8% | 0.00% | – |
| Q3 2014 | $43,000 | -59.4% | 5,115 | -17.3% | 0.00% | – |
| Q2 2014 | $106,000 | -88.5% | 6,183 | -87.5% | 0.00% | – |
| Q1 2014 | $920,000 | – | 49,405 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |